HealthEquity (NASDAQ:HQY) Price Target Cut to $94.00 by Analysts at The Goldman Sachs Group

HealthEquity (NASDAQ:HQY) had its price target reduced by The Goldman Sachs Group from $107.00 to $94.00 in a research report report published on Thursday,Benzinga reports. They currently have a neutral rating on the stock.

Other equities analysts have also issued reports about the stock. JMP Securities increased their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Barrington Research reissued an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a research report on Friday, March 14th. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their target price for the stock from $120.00 to $115.00 in a report on Tuesday, March 25th. Finally, Royal Bank of Canada raised their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, HealthEquity has an average rating of “Buy” and a consensus price target of $112.23.

HealthEquity Price Performance

Shares of HQY stock opened at $86.96 on Thursday. The firm’s 50 day moving average is $103.63 and its 200-day moving average is $96.06. The firm has a market capitalization of $7.52 billion, a price-to-earnings ratio of 79.78, a PEG ratio of 1.60 and a beta of 0.62. HealthEquity has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

Several institutional investors have recently modified their holdings of HQY. Wealthfront Advisers LLC bought a new position in HealthEquity during the 4th quarter worth approximately $10,304,089,000. Vanguard Group Inc. grew its position in HealthEquity by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock worth $861,256,000 after purchasing an additional 99,624 shares in the last quarter. Wasatch Advisors LP grew its holdings in shares of HealthEquity by 6.6% in the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after acquiring an additional 483,269 shares in the last quarter. FMR LLC grew its position in HealthEquity by 2.4% during the fourth quarter. FMR LLC now owns 5,415,800 shares of the company’s stock valued at $519,646,000 after buying an additional 125,684 shares during the period. Finally, State Street Corp lifted its stake in HealthEquity by 0.8% in the third quarter. State Street Corp now owns 3,131,900 shares of the company’s stock valued at $256,346,000 after purchasing an additional 23,613 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.